REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $281 | -17.6% | 2,757 | -26.6% | 0.00% | -33.3% |
| Q1 2023 | $341 | +110.5% | 3,754 | -11.9% | 0.00% | +200.0% |
| Q4 2022 | $162 | -99.8% | 4,263 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $107,000 | -16.4% | 4,263 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $128,000 | -9.2% | 4,207 | -2.6% | 0.00% | 0.0% |
| Q1 2022 | $141,000 | -70.3% | 4,318 | -8.4% | 0.00% | -75.0% |
| Q3 2021 | $474,000 | -33.1% | 4,715 | -5.9% | 0.00% | -33.3% |
| Q2 2021 | $709,000 | +51.8% | 5,011 | +7.0% | 0.01% | -66.7% |
| Q1 2021 | $467,000 | -19.1% | 4,684 | +0.4% | 0.02% | -18.2% |
| Q4 2020 | $577,000 | +26.8% | 4,664 | -0.1% | 0.02% | +10.0% |
| Q3 2020 | $455,000 | -38.1% | 4,668 | -0.8% | 0.02% | -41.2% |
| Q2 2020 | $735,000 | +35.9% | 4,708 | +25.5% | 0.03% | +161.5% |
| Q1 2020 | $541,000 | -31.5% | 3,750 | -3.0% | 0.01% | -13.3% |
| Q4 2019 | $790,000 | +207.4% | 3,866 | +20.7% | 0.02% | +200.0% |
| Q3 2019 | $257,000 | -16.3% | 3,203 | -1.5% | 0.01% | -28.6% |
| Q2 2019 | $307,000 | +22.3% | 3,253 | +11.0% | 0.01% | +16.7% |
| Q1 2019 | $251,000 | – | 2,931 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |